Silence Therapeutics Plc (SLNCF)
4.00
0.00 (0.00%)
USD |
OTCM |
Sep 01, 16:00
Silence Therapeutics Research and Development Expense (Annual) : 60.29M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 60.29M |
| December 31, 2024 | 54.15M |
| December 31, 2023 | 44.99M |
| December 31, 2022 | 43.85M |
| December 31, 2021 | 42.29M |
| December 31, 2020 | 25.89M |
| December 31, 2019 | 16.98M |
| December 31, 2018 | 12.96M |
| December 31, 2017 | 10.20M |
| December 31, 2016 | 11.74M |
| December 31, 2015 | 10.87M |
| December 31, 2014 | 14.23M |
| December 31, 2013 | 8.464M |
| December 31, 2012 | 5.053M |
| December 31, 2011 | |
| December 31, 2010 |
| Date | Value |
|---|---|
| December 31, 2009 | |
| December 31, 2008 | |
| December 31, 2007 | |
| December 31, 2006 | |
| December 31, 2005 | |
| December 31, 2004 | |
| December 31, 2003 | |
| December 31, 2002 | |
| December 31, 2001 | 3.587M |
| December 31, 2000 | 4.539M |
| December 31, 1999 | |
| December 31, 1998 | |
| December 31, 1997 | 2.997M |
| December 31, 1996 | 1.538M |
| December 31, 1995 | 1.247M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Biodexa Pharmaceuticals Plc | 5.026M |
| NuCana Plc | 16.79M |
| Mereo BioPharma Group Plc | 17.81M |
| Compass Pathways Plc | 118.71M |
| HemoGenyx Pharmaceuticals Plc | -- |